A study of more than 45,000 women found that screening women according to their level of risk was as effective in detecting tumors as the one-size-fits-most screening currently recommended. By Roni ...

For stable, symptomatic patients with suspected CAD who are deemed to be at “minimal risk” using a CT-based tool, deferral of diagnostic testing is just as safe as the usual approach and is even ...

Approximately 80 percent of patients who have the hepatitis C virus may have been missed through EMR-reliant risk-based testing, according to research from the CDC. The paper, published in Clinical ...

The NCCN's new resource educates patients on genetic testing for hereditary cancer risk, focusing on breast, ovarian, pancreatic, and prostate cancers. Advances in genetic technology, spurred by the ...

The assay is designed to encourage informed patient-physician decision-making when choosing a treatment option in localised ...

Nelson Labs' Thor Rollins becomes a convener of ISO 10993-1, driving advancements in biocompatibility standards.

Clinicians who test for albuminuria provide better evidence-based care to their patients than those who do not, research finds. Screening for chronic kidney disease (CKD), particularly albuminuria, is ...

A prospective trial of gastrointestinal cancer patients showed the feasibility of preemptive genetic testing for DPYD/UGT1A1 variants associated with increased chemotherapy toxicity. Genotype-guided ...